Recent Quarter Total Invested
$1.31 B
Recent Quarter Institutional Ownership Percentage
103.37%
Total Invested of Last Quarter
$1.18 B
Ownership Percentage of Last Quarter
102.45%
Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 11/08/2024 | 11.66 M | $108.47 M | 0.79% | 9.38% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 10.97 M | $101.99 M | 11.71% | 8.82% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 10.72 M | $99.71 M | 7.17% | 8.63% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9.03 M | $83.97 M | 100.00% | 7.26% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 8.79 M | $81.70 M | 0.00% | 7.07% |
| VANGUARD GROUP INC | 11/13/2024 | 6.96 M | $64.75 M | 13.32% | 5.60% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 6.88 M | $64.02 M | 0.08% | 5.54% |
| STATE STREET CORP | 11/14/2024 | 5.64 M | $52.47 M | 9.87% | 4.54% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 4.25 M | $41.40 M | -4.23% | 3.42% |
| MORGAN STANLEY | 11/14/2024 | 3.78 M | $35.17 M | -4.82% | 3.04% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 3.55 M | $33.05 M | -1.73% | 2.86% |
| CITADEL ADVISORS LLC | 11/14/2024 | 3.03 M | $28.19 M | 3.36% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.47 M | $22.98 M | 2.02% | 1.99% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 2.42 M | $22.48 M | 13.27% | 1.94% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 2.33 M | $21.62 M | -7.92% | 1.87% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2024 | 2.12 M | $19.72 M | 3.89% | 1.71% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 1.78 M | $16.54 M | 84.21% | 1.43% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.75 M | $16.23 M | 73.22% | 1.40% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 1.59 M | $14.82 M | -4.46% | 1.28% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.59 M | $14.79 M | 96.93% | 1.28% |
| J. GOLDMAN & CO LP | 11/14/2024 | 1.49 M | $13.88 M | 13.78% | 1.20% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.46 M | $13.62 M | 18.89% | 1.18% |
| CANDRIAM S.C.A. | 11/13/2024 | 1.43 M | $13.27 M | 9.10% | 1.15% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.36 M | $12.63 M | -12.83% | 1.09% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.30 M | $12.06 M | 0.92% | 1.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.18 M | $10.94 M | 107.35% | 0.95% |
| TEJARA CAPITAL LTD | 11/13/2024 | 1.17 M | $10.84 M | -13.27% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.15 M | $10.67 M | 123.81% | 0.92% |
| INVESCO LTD. | 11/12/2024 | 938,484 | $8.73 M | 0.09% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 859,846 | $8.00 M | 1.00% | 0.69% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 807,650 | $7.51 M | 9.88% | 0.65% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 803,204 | $7.47 M | 123.11% | 0.65% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 693,263 | $6.45 M | -17.26% | 0.56% |
| ABRDN PLC | 10/25/2024 | 482,074 | $4.48 M | 223.81% | 0.39% |
| FISHMAN JAY A LTD/MI | 10/30/2024 | 418,000 | $3.89 M | 20.60% | 0.34% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 323,701 | $3.01 M | -70.93% | 0.26% |
| PDT PARTNERS, LLC | 11/14/2024 | 319,715 | $2.97 M | 0.00% | 0.26% |
| TWO SEAS CAPITAL LP | 11/14/2024 | 312,122 | $2.90 M | -59.05% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 311,059 | $2.89 M | -20.28% | 0.25% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 276,818 | $2.57 M | 6.68% | 0.22% |
| BARCLAYS PLC | 11/19/2024 | 253,392 | $2.36 M | 148.15% | 0.20% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 252,151 | $2.35 M | -2.02% | 0.20% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 250,000 | $12,500 | -50.00% | 0.20% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 244,386 | $2.27 M | 100.00% | 0.20% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 237,174 | $2.21 M | 730.01% | 0.19% |
| AMI ASSET MANAGEMENT CORP | 10/25/2024 | 223,681 | $2.08 M | 36.23% | 0.18% |
| UBS GROUP AG | 11/14/2024 | 220,194 | $2.05 M | -28.87% | 0.18% |
| SWISS NATIONAL BANK | 11/07/2024 | 203,600 | $1.89 M | 0.00% | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 192,099 | $1.79 M | 100.00% | 0.15% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 182,800 | $1.70 M | -62.59% | 0.15% |
Arcutis Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ARQT shares?
During the previous two years, 217 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 11.66 M
Rubric Capital Management LP: 10.97 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 10.72 M
BlackRock Funding, Inc. /DE: 9.03 M
Frazier Life Sciences Management, L.P.: 8.79 M
VANGUARD GROUP INC: 6.96 M
-
What percentage of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors?
103.37% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ARQT ?
Institutional investors have bought a total of 135.96 M shares in the last 24 months. This purchase volume represents approximately $1.69 B in transactions.